Mechanisms of renal repair and survival following acute injury

Seminars in Nephrology

Volumn 18, Issue 5, 1998, Pages 523-532

  Safirstein, Robert ^a   DiMari, John ^a   Meavesi, Judit ^b   Price, Peter ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645854071     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Holbrook NJ, Fomace A Jr: Response to adversity: Molecular control of gene activation following genotoxic stress. New Biol 3:825-833, 1991
2. Bravo R: Genes induced during the GO/GI transition in mouse fibroblasts. Cancer Biol 1:37-46, 1990
3. Derijard B, Raingeaud T, Barrett I, et al: Independent human MAP kinase signal transduction pathways defined by MEK and MAKK isoforms. Science 267:682-685, 1995
4. Kyriakis JM, Banerjee P, Nikolakaki E, et al: The stress-activated protein kinase subfamily of c-jun kinases. Nature 369:156-160, 1994
5. Davis RJ: MAPKS: New JNK expands the group. TIBS 19:470-473, 1994
6. Pombe CM, Bonventre JV, Avruch J, et al: The stress activated protein kinases are major c-jun amino-terminal kinases activated by ischemia and reperfusion. J Biol Chem 269:26546-26551, 1994
7. DiMari JF, Megyesi J, Udvarhelyi N, et al: N-acetyl cysteine ameliorates ischemie renal failure. Am J Physiol 272:F393-398, 1997
8. Xia Z, Dickens M, Raingeaud J, et al: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331, 1995
9. Canman C, Gilmer T, Coutts S, et al: Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev 9:600-611, 1995
10. Bybee A, Thomas N: Cell cycle regulation. Blood Rev 5:177-192, 1991
11. Sherr C, Roberts J: Inhibitors of mammalian G1, cyclin dependent kinases. Genes Dev 9:1149-1163, 1995
12. Price PM, Megyesi J, Udvarhelyi N, Safirstein RL: The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure. Am J Physiol 271:F1211-F1216, 1996
13. Liu Yusen, Martindale JL, Gorospe M, Holbrook NJ: Regulation of p21WAFl/CIPl expression through mitogenactivated protein kinase signaling pathway. Cancer Res 56:31-35, 1996
14. Shim J, Lee H, Park J, et al: A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 381:804-806, 1996
15. Wang J, Walsh K: Resistance to apoptosis conferred by cdk inhibitors during myocyte differentiation. Science 273:359-361, 1996
16. Poluha W, Poluha DK, Chang B, et al: The cyclindependent kinase inhibitor p21WAFl is required for survival of differentiating neuroblastoma cells. Mol Cell Biol 16:1335-1341, 1996
17. Gorospe M, Wang X, Guyton KZ, Holbrook NJ: Protective role of p21 Wafl/Cipl against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol Cell Biol 16:6654-6660, 1996
18. Megyesi J, Safirstein RL, Price PM: Induction of p21 (Wafl/CIPl/SDI1) in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 101:777-782, 1998
19. Coimbra TM, Cieslinski DA, Humes HD: Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity. Am J Physiol 259:F438-F443, 1990
20. Norman JT, Tsau YK, Bacay A, et al: Epidermal growth factor accelerates functional recovery from ischaemic acute tubular necrosis in the rat: Role of the epidermal growth factor receptor. Clin Sei 78:445-450, 1990